- Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemiaS L Soignet
Developmental Chemotherapy, Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University Medical College, 1275 York Avenue, New York, NY 10021, USA
Cancer Chemother Pharmacol 44:417-21. 1999....
- Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet
Memorial Sloan Kettering Cancer Center and Department of Medicine, New York, New York 10021 6007, USA
Oncologist 6:11-6. 2001..Additional trials are under way to evaluate the use of this agent alone or as part of a chemotherapy regimen for consolidation and maintenance of patients with APL...
- United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet
Leukemia and Developmental Chemotherapy Services, Department of Medicine, Memorial Sloan Kettering Cancer Center and Joan and Sanford Weill Medical College of Cornell University, New York, NY 10021, USA
J Clin Oncol 19:3852-60. 2001..To determine the safety and efficacy of arsenic trioxide (ATO) in patients with relapsed acute promyelocytic leukemia (APL)...